• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    AdvisorShares Dorsey Wright Short ETF (NQ:DWSH)

    6.700 +0.040 (+0.60%)
    Streaming Delayed Price Updated: 11:50 AM EDT, Oct 6, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about AdvisorShares Dorsey Wright Short ETF

    Humana Stock Rises After Insurer Reaffirms Full-Year Earnings Guidance
    Via Stocktwits
    Illumina Stock Surged 6% Today – Here’s Why
    The company announced that its new business will focus on developing data assets, software, and artificial intelligence to drive drug development. 
    Via Stocktwits
    Topics Artificial Intelligence
    VF Corp To Sell Dickies Brand To Bluestar Alliance For $600M
    Via Stocktwits
    Campbell’s Gains Wall Street Confidence With Multiple Price Target Hikes, Retail Chatter Surges
    Via Stocktwits
    Sarepta Just Got A Good Restructuring Deal For $700M Debt, But Stock Tumbles 7% – Here’s Why
    Although the company has managed to push back the maturity of the new debt to 2030, it is also offering cash and common stock to certain investors as part of the deal. 
    Via Stocktwits
    This Stock Has Tumbled 50% In One Year, Gets A Price Target Cut Today – But Retail Believes $400-450 Is A Good Entry Point
    Truist, however, kept a ‘Buy’ rating on the shares. 
    Via Stocktwits
    This Pharma Stock Shot Up 8% Today, Gets A Price Target Hike From Wells Fargo: Here’s Why Retail Sees Opportunity
    Via Stocktwits
    Sarepta Draws Wall Street Ire After Third Patient Death This Year: Analyst Says ‘Deeply Concerning’ The Incident Wasn’t Reported Earlier
    Via Stocktwits
    Why Did Sarepta Stock Jump 20% On Tuesday? Here’s What JPMorgan, Bernstein, Barclays Said About Elevidys
    JPMorgan upgraded Sarepta to ‘Neutral’ from ‘Underweight’ with a $24 price target. 
    Via Stocktwits
    Topics Death
    Regeneron’s Therapy For Blood Cancer Bags FDA Approval: REGN Stock Jumps
    While Lynozyfic was granted accelerated approval based on response rate in the LINKER-MM1 trial, continued approval may depend upon verification and description of clinical benefit in a confirmatory... 
    Via Stocktwits
    Topics Death
    5 Low-Risk ETFs To Buy Amid Historic Bond Turmoil
    Investors are increasingly exploring diversified strategies that help to protect their portfolios from downside risk. 
    Via Talk Markets
    Topics ETFs
    Wall Street Tumbles On Renewed Fears: 5 ETFs Standing Tall
    Though terrible trading in the stock world pushed the ETF space into deep red on the day, a few ETFs still saw strength. 
    Via Talk Markets
    5 ETFs That Gained Double Digits in Q2
    These funds have been the quarter’s star performers and could also be winners next quarter if the current trends continue. 
    Via Talk Markets
    5 ETFs That Gained Double Digits In Q2
    While most corners of the market were deep in the red, a few have performed well. Let's take a look at the ETFs that have been the quarter’s star performers, as they could also be winners next quarter... 
    Via Talk Markets
    Forget Recession Fears With These ETFs
    Here are five ETFs that could provide some shelter from the crisis and benefit investors’ portfolio. 
    Via Talk Markets
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.